May 2022 – REGENHEALTHSOLUTIONS (RHS)

PIER MARIA FORNASARI
2022-05-31

Recent progress in cell therapy research: a review in Nature outlines engineering disciplines, genome and epigenome editing, synthetic biology and biomaterial-mediated immune modulation.

Given recent progress in cell therapy research, it is clear that the engineering disciplines outlined in this Review will play an increasing role in the creation of new product pipelines with improved safety, efficacy and accessibility for patients. Recent scientific advances have not only demonstrated the potential impact of technologiesdeveloped by each of these fields,

No Comments InADVANCED THERAPY MEDICINAL PRODUCT REGENERATIVE MEDICINE

PIER MARIA FORNASARI
2022-05-31

Neutrophils “reverse migration”: new insight into inflammation processes

Understanding how a type of white blood cell called a neutrophil behaves at the site of a tissue injury might one day lead to advances in wound repair and inflammation, said Dr. Anna Huttenlocher, at the first in-person NIH Director’s Wednesday Afternoon Lecture in Lipsett Amphitheater since March 2020. Known as the immune system’s first

No Comments InRESEARCH

PIER MARIA FORNASARI
2022-05-30

‘Remote-controlled’ CAR-T cell therapy safer, more potent in Stanford mouse studies

Stanford researchers modified anti-cancer CAR-T cells so they can be controlled with an oral drug. The modified cells are safer, more potent and more active against solid tumors in mice. A cancer treatment that uses a patient’s own genetically modified immune cells to attack cancer cells is safer and more effective when it can be

No Comments InCAR-T

PIER MARIA FORNASARI
2022-05-30

Study: Patients with severe COVID-19 pneumonia treated with leukotriene inhibitors are more likely to survive, University of Buffalo researchers find

In a retrospective study based on big data, the researchers found that Leukotriene Inhibitors (LTI)s prevented death in COVID-19 patients with low oxygen saturation University at Buffalo biomedical informatics researchers have found that patients hospitalized with COVID-19 pneumonia had a 13.5% survival advantage when treated with a combination of leukotriene inhibitors (LTIs) and the steroid

No Comments InCovid-19

PIER MARIA FORNASARI
2022-05-30

Long COVID poses risks to vaccinated people, too

While risks higher for the unvaccinated, study points to need for more tools against the virus Vaccinated people with mild breakthrough COVID-19 infections can experience debilitating, lingering symptoms that affect the heart, brain, lungs and other parts of the body, according to researchers at Washington University School of Medicine in St. Louis and the Veterans

No Comments InCovid-19

PIER MARIA FORNASARI
2022-05-21

‘Cell pores’ discovery and a new drug give hope to millions of brain and spinal cord injury patients

Scientists from the University of Birmingham have shown an existing drug may reduce damage after spinal cord injury, by blocking the inflammatory response in the spinal cord. Their research, published today in Clinical and Translational Medicine, demonstrates that AZD1236, a drug developed by AstraZeneca, can significantly reduce “secondary damage” caused by the body’s response to spinal

No Comments InBRAIN

PIER MARIA FORNASARI
2022-05-21

Amyloid production induced by neutrophil elastase as possible mechanism behind enigmatic symptoms in Severe Covid-19

In severe covid-19 and long-term covid, disorders of blood coagulation often occur. Now, researchers at LiU have discovered that the body’s immune system can affect the nail protein on the surface of the sars-cov-2 virus so that it forms misfolded protein, so-called amyloid. The findings point to a possible link between harmful amyloid formation and covid-19 symptoms.

No Comments InCovid-19

PIER MARIA FORNASARI
2022-05-21

BWH Scientists Develop ‘Off the Shelf’ Engineered Stem Cells to Treat Aggressive Glioblastoma

Glioblastomas (GBMs) are highly aggressive cancerous tumors of the brain and spinal cord. Brain cancers like GBM are challenging to treat because many cancer therapeutics cannot pass through the blood-brain barrier, and more than 90 percent of GBM tumors return after being surgically removed, despite surgery and subsequent chemo- and radiation therapy being the most

No Comments InCANCER

PIER MARIA FORNASARI
2022-05-19

COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response

The inflammatory disorders share similar underlying molecular patterns, a UC San Diego study reports; findings may improve disease diagnosis and treatment and support new drug targets for MIS-C The emergence of COVID-19 had doctors racing to define and treat the new disease, but they soon discovered it was not the only novel illness caused by

No Comments InCovid-19

PIER MARIA FORNASARI
2022-05-19

Unicef Warns Ukraine Invasion is Fueling ‘Catastrophic’ Malnutrition Among Children

Soaring food prices driven by the war in Ukraine and pandemic-fuelled budget cuts set to drive up both need for, and cost of life-saving therapeutic food treatment, the latter by up to 16 per cent The number of children with severe wasting was rising even before war in Ukraine threatened to plunge the world deeper

No Comments InWELLNESS

REGENERATIVE AND PERSONALISED MEDICINE

DIGITAL HEALTHCARE

Archives: 2022-05-31

Recent progress in cell therapy research: a review in Nature outlines engineering disciplines, genome and epigenome editing, synthetic biology and biomaterial-mediated immune modulation.

Neutrophils “reverse migration”: new insight into inflammation processes

‘Remote-controlled’ CAR-T cell therapy safer, more potent in Stanford mouse studies

Study: Patients with severe COVID-19 pneumonia treated with leukotriene inhibitors are more likely to survive, University of Buffalo researchers find

Long COVID poses risks to vaccinated people, too

‘Cell pores’ discovery and a new drug give hope to millions of brain and spinal cord injury patients

Amyloid production induced by neutrophil elastase as possible mechanism behind enigmatic symptoms in Severe Covid-19

BWH Scientists Develop ‘Off the Shelf’ Engineered Stem Cells to Treat Aggressive Glioblastoma

COVID-19, MIS-C and Kawasaki Disease Share Same Immune Response

Unicef Warns Ukraine Invasion is Fueling ‘Catastrophic’ Malnutrition Among Children